Quick Details
- Batch No: PL2645/2:Expiry date: 03/2021
- Processing Time:3 days
- Port:Hethrow airport
- Supply Ability: 100 Boxes Per Week
- Brand Name:soliris 300mg
Soliris 30mg is a humanised monoclonal antibody that is a first-in-class terminal complement inhibitor and the first therapy approved for the treatment of paroxysmal nocturnal
hemoglobinuria (PNH) , a rare, progressive, and sometimes life-threatening disease.
Its use and Indications
Soliris is indicated for
The treatment of patients of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis.
The treatment of patients with atypical haemolytic uremic syndrome (aHUS) to inhibit complement- mediated thrombotic microangiopathy.
Treatment
For treatment related information, please consult your treating Physician.
How supplied:
Soliris is supplied as 300 mg single-use vials each containing 30 ml of 10 mg/ml sterile, preservative-free eculizumab solution.
Storage and handling
Soliris vials must be stored in the original carton until time of use under refrigerated conditions at 2-8°C and protected from light.
DO NOT FREEZE, DO NOT SHAKE
How do we source the Drug?
Super Specialities Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating
Oncologist is mandatory, with all relevant documents associated with its procurement is essential.
Soliris 30mg is a humanised monoclonal antibody that is a first-in-class terminal complement inhibitor and the first therapy approved for the treatment of paroxysmal nocturnal hemoglobinuria
(PNH) , a rare, progressive, and sometimes life-threatening disease.
Its use and Indications
Soliris is indicated for
The treatment of patients of patients with paroxysmal nocturnal hemoglobinuria (PNH) to reduce hemolysis.
The treatment of patients with atypical haemolytic uremic syndrome (aHUS) to inhibit complement- mediated thrombotic microangiopathy.
Treatment
For treatment related information, please consult your treating Physician.
How supplied:
Soliris is supplied as 300 mg single-use vials each containing 30 ml of 10 mg/ml sterile, preservative-free eculizumab solution.
Storage and handling
Soliris vials must be stored in the original carton until time of use under refrigerated conditions at 2-8°C and protected from light.
DO NOT FREEZE, DO NOT SHAKE
How do we source the Drug?
RCC Pharma will assist in sourcing the drug through its efficient network, across the globe, and ensure the delivery is prompt. However, a valid prescription from the treating Oncologist is
mandatory, with all relevant documents associated with its procurement is essential.